$RNXT The pivotal Phase III CouGar study will be the second clinical trial evaluating RenovoGem™, a combination drug-device product, in a difficult-to-access solid tumor cancer. Learn more:
https://bit.ly/4asSZjH
$RNXT #BileDuctCancer
https://twitter.com/RenovoRx/status/1737914614195577273